MINNEAPOLIMEDIA EDITORIAL | Minnesota Must Not Surrender Its Healthcare Institutions Without Giving Patients a Decisive Voice

The acquisition of North Memorial Health and the earlier combination of St. Luke’s with Aspirus show that healthcare consolidation in Minnesota is no longer a distant concern. With Allina Health and Essentia Health now involved in major pending transactions, state regulators must protect affordability, essential services, workers and meaningful local control.

MINNEAPOLIS, MN (October 27, 2026).

Minnesota’s healthcare system is undergoing a transfer of institutional control on a scale that should concern every patient, worker, employer and taxpayer in the state.

This is no longer a discussion about transactions that might happen someday. Several significant combinations have already been completed. Others have advanced from exploratory discussions to signed agreements and formal regulatory review.

Wisconsin-based Aspirus Health completed its affiliation with Duluth-based St. Luke’s in March 2024. South Dakota-based Sanford Health completed its acquisition of North Memorial Health on September 1, 2026. Sanford had already completed its combination with Wisconsin-based Marshfield Clinic Health System in January 2025, creating a large regional organization operating across several states.

Two additional transactions could reshape much of the remaining healthcare landscape in Minnesota.

Allina Health has signed a definitive agreement to join California-based Sutter Health. If regulators approve the transaction and it closes, Allina would become Sutter’s Upper Midwest Division while retaining the Allina name and its regional headquarters in Minneapolis.

HealthPartners and Essentia Health signed a definitive agreement on September 29. The organizations intend to combine as a single nonprofit system operating under the HealthPartners name. They have set January 1, 2027, as their target date, subject to regulatory approval.

Each organization describes its proposed combination in terms of stability, investment, access, quality and administrative efficiency. Those goals deserve serious consideration. Minnesota hospitals face legitimate financial pressures arising from labor shortages, inadequate government reimbursement, expensive technology, rising drug costs and the difficulty of sustaining specialized services across urban and rural communities.

Size can provide important advantages. A larger organization may have more capital, greater purchasing power, broader clinical expertise and a stronger ability to spread costs across numerous hospitals and clinics. A financially stronger partner may keep a vulnerable hospital operating when independence is no longer sustainable.

Those possible advantages do not justify automatic approval or passive public acceptance.

Healthcare institutions are not ordinary businesses. A hospital cannot be evaluated in the same manner as a retail chain, warehouse or technology company. Hospitals hold charitable assets accumulated through tax advantages, public support, philanthropy and generations of community investment. They provide emergency care, maternity services, trauma treatment, mental health services and other functions that communities cannot readily replace after they disappear.

When control of a major healthcare institution changes hands, the consequences extend beyond the boardroom. Patients may face different prices, insurance networks, billing policies and referral practices. Workers may encounter new staffing rules, benefit structures and management systems. Communities may lose influence over decisions involving service reductions, clinic closures and capital investment.

Minnesota therefore has an obligation to decide whether its healthcare institutions are becoming stronger through consolidation or simply more remote from the people they serve.

Completed Transactions Require Continuing Scrutiny

The completion of a merger must not end the public examination of that transaction.

The Aspirus-St. Luke’s combination provides one early test of Minnesota’s healthcare transaction law. St. Luke’s transferred control to Aspirus in March 2024, creating a system with hospitals and outpatient facilities across Minnesota, Wisconsin and Michigan’s Upper Peninsula.

Before the transaction closed, the Minnesota Attorney General secured a five-year oversight agreement. Aspirus committed to invest at least $300 million in St. Luke’s Duluth within eight years. It also agreed to maintain St. Luke’s as a full-service acute-care hospital and regional referral center, preserve Lake View Hospital in Two Harbors as an acute-care hospital for at least 10 years, honor labor contracts and continue charity care and specified clinical services.

Those commitments were consequential. They converted corporate assurances into obligations subject to reporting and state oversight. The agreement also recognized that the public interest cannot be protected through optimism alone.

The state must now publish enough information for patients and workers to determine whether those promises are being kept.

The same principle applies to Sanford’s acquisition of North Memorial Health.

Sanford and North Memorial announced in May that North Memorial would become a subsidiary of Sanford. After reviewing the transaction and receiving public comments, the Attorney General reached a 10-year oversight agreement with the organizations in August. The combination closed on September 1.

The agreement requires $600 million in investments, including $500 million connected to Maple Grove Hospital and $100 million for Robbinsdale Hospital. It requires the continuation of North Memorial’s Level I trauma center and an extensive range of core services in Robbinsdale for 10 years. It also includes commitments involving charity care, public insurance programs, behavioral health, labor agreements and emergency transportation.

Sanford and the merged system must meet quarterly with the Attorney General’s Office and submit annual reports for 10 years. Those provisions establish a meaningful enforcement structure. They also demonstrate why merger promises must be written, measurable and legally enforceable.

North Memorial’s future is now tied to Sanford’s willingness and ability to fulfill those commitments. The transaction cannot simply disappear from public attention because ownership has changed and the closing documents have been signed.

Minnesotans deserve regular information about whether promised investments have occurred, whether clinical services remain available, whether staffing has changed and whether the cost of care has risen. Annual reports should be made public except for legitimately protected information. Patients should not have to file repeated data requests or search through obscure regulatory records to determine whether a healthcare system is complying with an agreement made on their behalf.

Minnesota Is Confronting Several Transactions at Once

The pending Allina-Sutter transaction would reach deeply into the daily healthcare choices of residents throughout Minnesota and western Wisconsin.

Allina operates 12 hospital campuses, more than 90 clinics, pharmacies, specialty centers, home health services and emergency medical transportation. Under the definitive agreement, Allina would become Sutter Health’s Upper Midwest Division. Allina would retain its name, brand and Minneapolis headquarters, while Sutter’s leadership would oversee the combined system.

The parties have said they expect the transaction to close by the end of 2026, subject to state and federal regulatory review.

Retaining a familiar name does not necessarily preserve local control. The central questions involve governance authority, capital allocation, service decisions, pricing policies and the legal rights of Minnesota communities after the transaction closes.

Regulators must determine who will control decisions about hospital investments, clinic closures and service changes. They must examine whether the regional board will possess genuine authority or merely offer advice to executives headquartered in California.

The organizations should also be required to identify which commitments are binding and which represent present intentions that future leaders could revise. Broad promises to improve care or expand access are not adequate substitutes for enforceable standards.

The proposed HealthPartners-Essentia transaction presents another set of questions.

HealthPartners is both a healthcare provider and a health insurer. It operates eight hospitals and more than 90 clinics and outpatient facilities, employs approximately 28,000 people and serves more than 1.4 million patients. Its insurance operations cover roughly 1.6 million members.

Essentia operates 14 hospitals and approximately 80 clinics, with about 16,500 employees serving communities in Minnesota, Wisconsin and North Dakota.

Their proposed combination would create a 22-hospital organization with extensive influence over healthcare delivery and insurance coverage across the region. The combination may offer clinical coordination and financial strength. It could also increase the power of one organization in negotiations involving hospitals, physicians, employers and patients.

The Attorney General has correctly opened a review and invited community input. That review must examine the full competitive impact of combining a major insurer with an extensive provider network that reaches from the Twin Cities to northeastern Minnesota and neighboring states.

Regulators must ask whether independent physicians and competing healthcare systems would receive fair access to HealthPartners insurance networks. They must determine whether the combined organization could steer patients toward affiliated facilities even when other providers offer more affordable or appropriate care.

The review should also examine whether Essentia’s communities would retain influence over service decisions after authority moves into a larger organization headquartered in Bloomington.

These questions do not presume that either transaction should be rejected. They establish the minimum standard of review appropriate when organizations serving millions of patients propose a permanent change in control.

Consolidation Does Not Automatically Lower Costs

Healthcare organizations commonly defend consolidation by pointing to economies of scale. They argue that larger systems can negotiate better prices for supplies, coordinate electronic medical records, reduce duplication and spread administrative costs across more facilities.

Some of those efficiencies may occur. The critical question is whether patients receive the benefit.

Evidence from Minnesota provides reason for caution. University of Minnesota researchers examined the acquisition of three multispecialty clinic systems in the Minneapolis-St. Paul area. Four years after the acquisitions, physician prices at the acquired clinics were between 32 percent and 47 percent higher than researchers estimated they would have been without the acquisitions. Prices also increased at clinics already owned by the acquiring systems.

The study did not prove that every healthcare acquisition will produce the same result. It did demonstrate that size can increase negotiating power without producing lower prices for patients and insurers.

When one system controls more hospitals, clinics and specialists, insurance companies have fewer practical alternatives. Excluding the system from an insurance network may become impossible because employers and patients expect access to its facilities. That leverage can produce higher negotiated prices, which eventually appear in insurance premiums, deductibles and employer healthcare costs.

Patients may never see the negotiation that produced those prices. They experience the result when a procedure costs more, a facility fee appears on a bill or an insurance premium rises at the next enrollment period.

Regulators must therefore require transaction-specific affordability commitments. Systems seeking approval should explain how the combination will affect negotiated prices, facility fees, charity care, collection practices and out-of-pocket costs.

Claims about efficiency should be supported by measurable savings targets. If executives project administrative savings, regulators should ask what percentage will be returned to patients and purchasers. If the savings will instead finance expansion, debt payments or executive compensation, the public should be told plainly.

Nonprofit Status Does Not Eliminate the Need for Oversight

The major organizations involved in these Minnesota transactions are nonprofits. That legal status matters, but it does not eliminate concerns about market power, executive decision-making or accountability.

A nonprofit hospital does not distribute profits to private shareholders. It can still accumulate large reserves, pay substantial executive compensation, acquire competitors, reduce services and exercise considerable pricing power.

Minnesota communities have contributed to the value of these institutions through charitable donations, tax exemptions, public infrastructure, government reimbursements and decades of patient revenue. Those accumulated assets carry a public purpose.

Minnesota law recognizes this principle. Its healthcare transaction statute requires large entities to provide advance notice and extensive financial, operational and governance information. The law prohibits transactions that substantially lessen competition or tend to create a monopoly or monopsony.

The Attorney General may seek to block or unwind a transaction that violates the law or runs contrary to the public interest. The statutory review considers affordability, access, services for underserved populations, medical education, workforce conditions, employment and the broader healthcare market.

This framework gives Minnesota a stronger foundation than it possessed several years ago. It remains incomplete.

The law says the Attorney General or health commissioner may hold public listening sessions. Public participation should not depend on discretion when control of a major hospital system is at stake. Hearings should be mandatory for transactions above a substantial revenue or patient-volume threshold.

Communities should receive enough information to participate intelligently. That includes governance documents, investment commitments, planned staffing changes, anticipated service changes and understandable summaries of how the transaction may affect prices.

A hearing held after the major terms have been negotiated offers only limited influence. Public participation should begin early enough for concerns to shape the agreement, not merely be recorded before approval.

Lobbying Deserves Disclosure, Not Unsupported Accusations

Minnesotans are justified in asking how large healthcare systems influence legislation and regulatory policy. These organizations possess substantial legal, financial and lobbying resources. Patients, independent clinicians and small community organizations rarely possess comparable access.

That imbalance deserves investigation. It does not justify claiming, without evidence, that lobbying caused regulators to approve a particular transaction.

A responsible editorial must separate a reasonable concern from a proven fact.

Minnesota should require complete disclosure of lobbying expenditures connected to healthcare transaction laws, antitrust policy, nonprofit oversight and individual mergers. The public should know which firms and lobbyists represented the parties, which agencies or legislators were contacted and which policy changes were sought.

The Legislature should also provide resources for independent consumer representation during major transaction reviews. Patients should not be expected to match corporate legal teams through volunteer testimony alone.

Consumer advocates, labor representatives, rural communities, disability organizations and public insurance beneficiaries should have access to independent experts capable of reviewing complicated financial and governance documents.

Transparency is not an accusation of wrongdoing. It is the basic condition required for public confidence.

Patients Need Influence After Closing

Public participation must continue after a healthcare transaction is completed.

The most consequential decisions often occur years later. A new parent organization may initially preserve services and staffing, then change course when financial pressures, leadership or corporate priorities shift.

Minnesota should require every major transaction to establish a patient and community advisory body with access to relevant performance information. Such a council should include patients, nurses, physicians, labor representatives, local officials and residents from communities directly served by the organization.

The council should receive advance notice of proposed hospital closures, service reductions, major staffing changes and relocation of specialized care. Its objections should trigger a formal public review before the changes take effect.

This would not give community members control over every clinical or financial decision. It would ensure that the people who depend on an institution are heard before essential services disappear.

For completed transactions, state oversight reports should track a consistent set of measures: prices, charity care, collection activity, staffing, patient wait times, emergency department capacity, service availability and capital investment.

The results should be published in a format that allows comparisons across years. A narrative assurance that a system remains committed to its mission is not enough.

Local Control Must Have Legal Meaning

Healthcare systems frequently promise to retain local leadership, familiar names and regional headquarters. Those promises can reassure communities, but they do not necessarily preserve authority.

Local control should be defined through governance rights.

Minnesota regulators should require clear answers about who appoints board members, who approves capital budgets, who controls real estate and who can authorize service closures. They should determine whether a Minnesota board can reject a decision from an out-of-state parent organization.

If the regional board lacks meaningful power, the transaction should not be presented as preserving local control.

The state should also protect charitable assets. Donations made to support a Minnesota hospital should remain dedicated to the community and purpose for which they were given. Land, buildings and investment funds accumulated under nonprofit ownership should not be redirected without a documented public benefit.

Exit provisions deserve particular attention. Regulators must plan for the possibility that a parent system later decides to sell, close or substantially reorganize a Minnesota facility. Communities need enforceable protections before such a crisis occurs.

Minnesota Should Judge Each Deal by Its Results

Opposing every merger would ignore the genuine financial challenges facing hospitals. Approving every merger would ignore the evidence that consolidation can raise prices and weaken competition.

Minnesota needs a disciplined standard that judges each transaction on its documented effects.

A transaction should proceed only when the applicant establishes that it will preserve or improve access, protect essential services, support the workforce and produce benefits that could not reasonably be achieved through a less restrictive arrangement.

The burden should rest with the organizations seeking the change in control. Communities should not be required to prove that a transaction will cause harm while the applicants rely on general promises about scale and innovation.

For completed transactions, the state must enforce every commitment and publish the results. For pending transactions, regulators must demand specific protections before approval. For future transactions, lawmakers should strengthen the public’s formal role and expand the state’s capacity to analyze prices, labor markets and service access.

Minnesota has already permitted significant changes in control. Aspirus now governs St. Luke’s. Sanford now controls North Memorial. The Allina-Sutter and HealthPartners-Essentia agreements could produce further transformation before the end of this year or the beginning of the next.

This is therefore not a warning about a theoretical future. The restructuring of Minnesota healthcare is underway.

The state still has an opportunity to determine the terms under which that restructuring occurs. It can insist on public disclosure, enforceable commitments, independent analysis and continuing accountability. It can refuse to treat a familiar logo or retained headquarters as proof that local control remains intact.

Minnesota’s hospitals were built to serve patients and communities. Their future cannot be decided solely by executives, consultants, lawyers and financial advisers.

Patients must have a decisive voice before control changes, while regulators review the agreement and throughout the years after a transaction closes.

Without that voice, Minnesota risks surrendering institutions that took generations to build and discovering too late that the most important decisions are being made somewhere else.

❤️ SUPPORT MINNEAPOLIMEDIA

---

STAY CONNECTED TO MINNEAPOLIMEDIA

Local stories matter. Subscribe free to MinneapoliMedia and receive independent news, community reporting and important updates from Minneapolis, the North Metro and communities across Minnesota.

SUBSCRIBE FREE: https://minneapolimedia.town.news/subscribe

MinneapoliMedia | Community. Culture. Civic Life